Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose—the randomized controlled HOMe aFers study

Abstract Background In patients with iron deficiency anemia, ferric carboxymaltose (FCM) and ferric derisomaltose (FDI) allow high-dose iron repletion. While FCM is reported to induce hypophosphatemia, the frequency of hypophosphatemia after an equivalent dosage of FDI had not been assessed prospect...

Full description

Bibliographic Details

Published in:	BMC Medicine
Main Authors:	I. E. Emrich, F. Lizzi, J. D. Siegel, S. Seiler-Mussler, C. Ukena, D. Kaddu-Mulindwa, R. D’Amelio, S. Wagenpfeil, V. M. Brandenburg, M. Böhm, D. Fliser, G. H. Heine
Format:	Article
Language:	English
Published:	BMC 2020-07-01
Subjects:	Hypophosphatemia FGF23 Iron deficiency anemia Ferric carboxymaltose Ferric derisomaltose
Online Access:	http://link.springer.com/article/10.1186/s12916-020-01643-5